Propanc Biopharma Appoints Belen Toledo to Evaluate Impact of Proenzyme Therapy on Tumor ...

Retrieved on: 2021-01-28 14:03:45

Tags for this article:

Click the tags to see associated articles and topics

Propanc Biopharma Appoints Belen Toledo to Evaluate Impact of Proenzyme Therapy on Tumor .... View article details on hiswai:

Excerpt

Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing novel cancer treatments for ...

Article found on: finance.yahoo.com